Akihiro Koreki1, Jun Nakane2, Shinobu Kitada3, Takehiro Hamaya4, Hiromi Ishii3, Kasumi Akimoto4, Kyoko Aso4, Mitsumoto Onaya2. 1. Department of Neuropsychiatry, National Hospital Organization Shimofusa Psychiatric Medical Center, Japan. Electronic address: koreki.akihiro.th@mail.hosp.go.jp. 2. Department of Neuropsychiatry, National Hospital Organization Shimofusa Psychiatric Medical Center, Japan. 3. Department of Nursing, National Hospital Organization Shimofusa Psychiatric Medical Center, Japan; Department of Occupational Therapy, National Hospital Organization Shimofusa Psychiatric Medical Center, Japan. 4. Department of Occupational Therapy, National Hospital Organization Shimofusa Psychiatric Medical Center, Japan.
The coronavirus disease 2019 (COVID-19) has had a major impact on psychiatric day care services as well as general mental health services (Moreno et al., 2020; Tandon, 2020). Psychiatric day care services are provided to prevent the relapse of mental illnesses and facilitate the recovery of social functioning (Yoshimasu et al., 2002). In April 2020, the Japanese government issued a stay-at-home order, and, consequently, psychiatric day care services were discontinued. In response to the temporal tendency of the spread of COVID-19 decreasing, the government decided to lift the restriction in May and restart the services. However, the COVID-19infection status remains unstable, and there is a high risk of repeated discontinuation of the services, which may lead to relapse of mental illnesses among the service users. Therefore, there is an urgent need to establish evidence on the impact of service discontinuation due to COVID-19 on psychiatricpatients who receive day care services.Our psychiatric day care services comprise many programs (6 h/day), such as exercise, craft, recreation, and skill training. Due to the restrictions imposed by the Japanese government, the services were discontinued from 8 April 2020 to 25 May 2020. During the period of discontinuation, the medical staff called the patients regularly (on a daily to weekly basis, depending on the case) to follow up on their clinical situation. When the services were restarted, the patients were asked to complete a simple questionnaire, which was clinically designed to evaluate their situation and was used to help restart the services.In the present study, the patients’ questionnaire responses and clinical information were analysed. The procedure of this study was approved by the Institutional Review Board of the Shimofusa Psychiatric Medical Center (020716002). Forty-five patients (mean age: 45.7 ± 15.0 years, female = 15, schizophrenia/schizoaffective disorder = 30, living alone = 12) completed the self-report questionnaire (response rate: 100 %). The questionnaire included an introduction and 10 items; each item had three choices (Yes, No, and Unknown). The introduction clarified that the items were regarding the discontinuation of services due to COVID-19. The following items were included: 1. Did you maintain your regular routine? 2. Were your sleeping patterns disrupted? 3. Did you do any exercise? 4. Did you continue taking your medications? 5. Did your symptoms worsen? 6. Did you want to go to day care? 7. Did you want to discontinue your day care services? 8. Did you complete your housework and/or engage in hobbies? 9. Were you stressed? 10. Did you experience anything good? In the analysis, all items were converted to binary data (yes or not yes [i.e., no/unknown]). In addition, the patients’ clinical characteristics (age, sex, diagnosis [F2 or not], duration of illness, duration of services, living arrangement [alone or with someone], use of home nursing services, and frequency of the day care services) were obtained from their medical records. Item 5 (‘yes’ indicated recurrence of symptoms) was selected as a dependent variable. In a pre-analysis screening, each variable was evaluated using the Student’s t-test or Fisher’s exact test (two-tailed) between patients with and without recurrence. Subsequently, age, sex, and significant factors found in the screening were included in the logistic analysis as independent variables. A p-value <0.05 was considered significant.Ten patients (22.2 %) reported symptom exacerbation. Disrupted sleeping patterns (16.8 %), stress (42.2 %), and loss of motivation regarding day care services (15.6 %) were also reported. In contrast, 16.8 % maintained their regular routines, 68.9 % exercised, 97.8 % continued taking their medications, 68.9 % expressed their desire to receive the day care services, 73.3 % completed their housework and/or engaged in hobbies, and 53.3 % experienced something good. The screening showed that maintaining a regular routine (p = 0.048) and loss of motivation (p = 0.034) were significantly associated with exacerbation of symptoms. Logistic analysis revealed that maintaining a regular routine (p = 0.036, odds ratio [OR] = 0.16 [confidence interval: 0.02–0.84]) and loss of motivation (p = 0.023, OR = 10.42 [1.52–99.50]) were significant factors. Although the present study had many limitations (small sample size, limitations related to study design, and self-report nature), the findings suggest that maintaining a regular routine played a crucial role in the prevention of recurrence when day care services were discontinued due to COVID-19. Loss of motivation regarding day care services might have been reflected in their recurrence. Contrary to our expectations, most patients survived through unpredictable and uncertain situations. Regular calls from medical staff might be beneficial in supporting patients’ regular routines. The COVID-19 pandemic is unpredictable and providing continuous support to help patients maintain their regular routines might be important to minimise the impact of COVID-19 on psychiatricpatients.
Funding
The authors report no sources of funding on this study.
Declaration of Competing Interest
The authors report no conflict of interest on this study.
Authors: Carmen Moreno; Til Wykes; Silvana Galderisi; Merete Nordentoft; Nicolas Crossley; Nev Jones; Mary Cannon; Christoph U Correll; Louise Byrne; Sarah Carr; Eric Y H Chen; Philip Gorwood; Sonia Johnson; Hilkka Kärkkäinen; John H Krystal; Jimmy Lee; Jeffrey Lieberman; Carlos López-Jaramillo; Miia Männikkö; Michael R Phillips; Hiroyuki Uchida; Eduard Vieta; Antonio Vita; Celso Arango Journal: Lancet Psychiatry Date: 2020-07-16 Impact factor: 27.083
Authors: Antonio José Sánchez-Guarnido; Valentina Lucena; Aurora Torrent; Laura Bosa; Virginia Martinez-López; Ana Cuartiles-Berenguer; Iolanda Batalla Journal: Front Psychol Date: 2022-03-10